ArticleCrohn's & colitis 3602025

Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.

Katsuyoshi Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.